Risk | High |
Patch available | YES |
Number of vulnerabilities | 1 |
CVE-ID | CVE-2020-1938 |
CWE-ID | CWE-22 |
Exploitation vector | Network |
Public exploit | Vulnerability #1 is being exploited in the wild. |
Vulnerable software Subscribe |
Oracle Health Sciences Empirica Signal Server applications / Other server solutions |
Vendor | Oracle |
Security Bulletin
This security bulletin contains one high risk vulnerability.
EUVDB-ID: #VU25502
Risk: High
CVSSv3.1: 8.8 [CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H/E:P/RL:O/RC:C]
CVE-ID: CVE-2020-1938
CWE-ID:
CWE-22 - Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
Exploit availability: Yes
DescriptionThe vulnerability allows a remote attacker to execute arbitrary code on the target system.
The vulnerability exists due to improper input validation in Apache Tomcat AJP connector. A remote attacker can send a specially crafted AJP request, include and execute arbitrary files on the target system.
Successful exploitation of this vulnerability may result in complete compromise of vulnerable system.
MitigationInstall update from vendor's website.
Vulnerable software versionsOracle Health Sciences Empirica Signal: 7.3.3
External linkshttp://www.oracle.com/security-alerts/cpujul2020.html?904660
Q & A
Can this vulnerability be exploited remotely?
Yes. This vulnerability can be exploited by a remote non-authenticated attacker via the Internet.
Is there known malware, which exploits this vulnerability?
No. We are not aware of malware exploiting this vulnerability. However, proof of concept for this vulnerability is available.